Changshan Pharma's Heparin Sodium Injection Wins Moldova Registration Certificate
On September 15, 2026, Changshan Pharma (300255) announced that its drug heparin sodium injection has obtained a drug registration certificate issued by Moldova's pharmaceutical regulatory authority.
The product receiving the Moldova registration approval is heparin sodium injection.
At present, overseas sales revenue from the company's heparin preparation products accounts for a relatively low proportion of the company's total operating revenue.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmaceuticals, with intensity 20/100 and 70% confidence over a medium term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.